Possibilities of using the protective activity of MIGI-K under conditions of radionuclide contamination

Experimental studies of mussel hydrolyzate MIGI-K show that this drug has the ability to increase the general and radiation resistance of the human body. Moreover, MIGI-K facilitates elimination of incorporated radionuclides from the body. A series of properties of this drug, in particular, the absence of toxicity or harmful side effects, makes it possible to apply MIGI-K as an adaptogen (a food supplement exhibiting therapeutic and preventive action and used to increase excretion of radionuclides from people who took part in the liquidation of the accident at the Chernobyl Nuclear Plant).